News

Press Releases

Inflection Biosciences Announces Pre-clinical Data to be Presented at 2018 AACR Targeting PI3K/mTOR

Dublin, Ireland, November 28th, 2018 – Inflection Biosciences Ltd, a private company developing innovative therapeutics for cancer, today...

Inflection Biosciences Announces Pre-clinical Data on IBL-202 to be Presented at ASH 2018 Meeting

Dublin, Ireland, November 22nd, 2018 – Inflection Biosciences Ltd, a private company developing innovative therapeutics for cancer, today...

Inflection Biosciences Announces Research Collaboration with MD Anderson Cancer Center.

Dublin, Ireland, November 1, 2018 – Inflection Biosciences Ltd, a private company developing innovative therapeutics for cancer, today...

Inflection Biosciences Announces Publication of Positive Data for Inhibitor Against CLL

Dublin, Ireland, July 17th, 2018 – Inflection Biosciences Ltd, a private company developing innovative therapeutics for cancer, today...

Inflection Biosciences and Trinity College Dublin Announce Immuno-Oncology Research Collaboration

Dublin, Ireland, April 16, 2018 – Inflection Biosciences Ltd, a private company developing innovative therapeutics for cancer, and the...

Inflection Biosciences Announces Presentation at the 2018 AACR Annual Meeting

Dublin, Ireland, April 13, 2018 – Inflection Biosciences Ltd, a private company developing innovative therapeutics for cancer, today...